Covid Nasal Spray

20230070870 · 2023-03-09

    Inventors

    Cpc classification

    International classification

    Abstract

    Direct instillation of a Chlorinated Solution into the Nasal passages to inactivate Covid 19 by way of Nasal spray of a Sodium Hypochlorite solution. For topical elimination of Covid 19, Solutions of 5-12.5 Parts Per Million; 5-12.5 mg. per Liter; 5-12.5% Solutions; are generally effective and considered safe by the EPA and FDA for indirect human consumption. While stronger solutions are recognized for eradication of the Coronavirus on inorganic impervious surfaces, these more dilute solutions have not previously been used for this application to the Nasal Mucosa and Nasopharynx of Humans. This new and revolutionary Process for use of Sodium Hypochlorite offers an alternative therapeutic and prophylactic modality in the war against Coronavirus (Covid-19). Sodium Hypochlorite is well known for disinfecting hard surfaces and its antimicrobial effects in higher concentrations. However, currently there are no biological products to suppress and eradicate Covid-19 in humans, besides Vaccination, Social Distancing, and Face Masks.

    Claims

    1. This Invention relates to the process and delivery of a dilute Sodium Hypochlorite solution ranging from 5 P.P.M. to 12.5 P.P.M.; 5-12 mg. per liter; 5-12.5 mg. % into the human Nasal Passages and Nasopharynx using an aerosol spray bottle or inhaler. (See FIG. 1))

    2. A Novel, Non-Obvious process to inactivate, retard, and suppress Covid-19 replication in nasal tissues reducing infection, transmission and recurrence of the Coronavirus, by the topical delivery of a dilute Sodium Hypochlorite solution to the mucosa of the human nasopharynx

    Description

    SUMMARY OF THE INVENTION

    [0005] Despite the initial optimism that the advent of Vaccines would eliminate or curtail future cases of Covid-19, many patients and the Scientific community are aware of many “break thru” cases and new variants. Vaccine success as to eradication against Delta, Omicron, and other variants is deemed to be about 50%. Recurrences of the Covid variants in vaccinated persons are sometimes asymptomatic or low grade, however the contagion remains real and pervasive, presenting a serious public health threat. Dr. West's Process is a safe, convenient, and easy to use nasal spray solution to interrupt the disease process in infected or exposed persons. While face masks may protect entry of the Virus into the Nasal passages, this Novel Process creates a second stage aimed at eradicating the Virus before it invades the tissue of the Nose and Nasopharynx. Just as the virus persists on hard surfaces for up 72 hours, the Virus exists on the human mucosal membranes before infection. Despite social distancing and the wearing of masks, this Process is necessary to interrupt the life cycle of this Covid-19 pathogen. After transmission or shedding, the Covid-19 virus resides on the mucous membranes of the Nose and Nasopharynx and is subject to the viricidal properties of this product, Covid Nasal Spray.

    [0006] The inventor Robert V. West III, M.D. is a Texas Physician and Board Certified in Emergency Physician practicing in the State of Texas for 42 years. Currently, due to recurring waves of Coronavirus strains and the advent of Telemedicine, nine states have extended their State Medical Licenses to Dr. West. He treats patients Nationwide and treats their C-19 infections as well. Dr. West has a B.A. in Natural Sciences and Doctor of Medicine, both from the University of Texas.